Valneva SE (VALN) EBIT (2021 - 2026)
Valneva SE (VALN) posted quarterly EBIT of -$27.0 million for Q1 2026, down 297.58% year-on-year from $13.6 million in Q1 2025, and up 15.72% on a QoQ basis from -$32.0 million in Q4 2025.
Valneva SE (VALN) EBIT (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported EBIT for 6 consecutive years, with -$27.0 million the latest figure, recorded in Q1 2026.
- Quarterly EBIT fell 297.58% year-over-year to -$27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$113.6 million (down 64.04% YoY) and the FY2025 annual result came in at -$93.4 million, down 715.6% from the prior year.
- EBIT grew to -$27.0 million in Q1 2026 per VALN's latest filing, from -$32.0 million in the prior quarter.
- Over the last five years, EBIT for VALN reached as high as $106.2 million in Q3 2022 and fell as low as -$150.2 million in Q2 2022.
- A 5-year average of -$19.3 million and a median of -$23.8 million in 2024 frame the typical range for EBIT.
- Annual changes were most pronounced in 2024 — EBIT surged 511.54% — and 2026, when it slumped 297.58%.
- Year by year, EBIT stood at -$64.1 million in 2022, then jumped by 55.8% to -$28.3 million in 2023, then grew by 16.15% to -$23.8 million in 2024, then slumped by 34.62% to -$32.0 million in 2025, then climbed by 15.72% to -$27.0 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$27.0 million, -$32.0 million, and -$42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -26.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.96 Mn |
| Dec 31, 2025 | -31.99 Mn |
| Sep 30, 2025 | -42.24 Mn |
| Jun 30, 2025 | -12.37 Mn |
| Mar 31, 2025 | -6.78 Mn |
| Dec 31, 2024 | -23.77 Mn |
| Sep 30, 2024 | -14.17 Mn |
| Jun 30, 2024 | -24.52 Mn |
| Mar 31, 2024 | 77.62 Mn |
| Dec 31, 2023 | -28.34 Mn |
| Sep 30, 2023 | -25.28 Mn |
| Jun 30, 2023 | -20.93 Mn |
| Mar 31, 2023 | -18.86 Mn |
| Dec 31, 2022 | -64.12 Mn |
| Sep 30, 2022 | 106.19 Mn |
| Jun 30, 2022 | -150.20 Mn |
| Mar 31, 2022 | -20.96 Mn |
| Dec 31, 2021 | 200.52 Mn |
| Sep 30, 2021 | -172.32 Mn |
| Jun 30, 2021 | -62.63 Mn |